New syringe design makes eye injection easier for doctors
NCT ID NCT07550504
First seen Apr 29, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study tested whether a pre-filled syringe of the drug SB11 (a biosimilar to ranibizumab) is easy for doctors to use when treating certain eye diseases. Thirty adults with wet age-related macular degeneration, macular edema from retinal vein occlusion, or myopic choroidal neovascularization received one injection. The main goal was to see how successfully doctors completed 12 preparation and injection steps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIC CHOROIDAL NEOVASCULARIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research site
Krakow, Poland
-
Research site
Olsztyn, Poland
Conditions
Explore the condition pages connected to this study.